SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer by Yuqian Yan, Lei Shi, Tao Ma, Liguo Wang, Haojie Huang

Subjects: Get full text

Assessment of the predictive power the radiation-induced lymphocyte apoptosis method in prostate cancer patients by Gyöngyvér Orsolya Sándor, Gyöngyi Farkas, Gábor Székely, Péter Ágoston, Kliton Jorgo, László Gesztesi, Tibor Major, Csilla Pesznyák, András Herein, Gábor Stelczer, Dalma Mihály, Georgina Fröhlich, Zsolt Jurányi, Zoltán Takácsi-Nagy, Csaba Polgár, Zsuzsa S. Kocsis

“…We recruited 49 patients with localized prostate cancer and performed RILA measurements before radiotherapy. …”
Get full text

Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey by Jennifer Le Guévelou, Paul Sargos, Piet Ost, Filippo Alongi, Stefano Arcangeli, Alejandro Berlin, Pierre Blanchard, Anna Bruynzeel, Olivier Chapet, Alan Dal Pra, Robert T. Dess, Matthias Guckenberger, Andrew Loblaw, Amar U. Kishan, Barbara Alicja Jereczek-Fossa, David Pasquier, Mohamed Shelan, Shankar Siva, Alison C. Tree, Costantinos Zamboglou, Stephane Supiot, Vedang Murthy, Thomas Zilli

Subjects: Get full text

BioLake: an RNA expression analysis framework for prostate cancer biomarker powered by data lakehouse by Qiaowang Li, Yaser Gamallat, Jon George Rokne, Tarek A. Bismar, Reda Alhajj

Subjects: Get full text

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer by Mikael Anttinen, Pietari Mäkelä, Pertti Nurminen, Heikki Pärssinen, Simona Malaspina, Teija Sainio, Mikael Högerman, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström

Subjects: Get full text

Chlamydia trachomatis Growth and Cytokine mRNA Response in a Prostate Cancer Cell Line by Ivan M. Petyaev, Naylia A. Zigangirova, Elena Y. Morgunova, Nigel H. Kyle, Elena D. Fedina, Yuriy K. Bashmakov

“…Furthermore, propagation of C. trachomatis in CWR-R1 cells leads to enhanced transcription of interleukin-6 and fibroblast growth factor-2, genes encoding two important proinflammatory cytokines implicated in the molecular mechanisms of chemoresistance of prostate cancer and its ability to metastasize. The possible roles of reactive oxygen species and impaired mitochondrial oxidation in the prostate cancer cell line are discussed as factors promoting the early stages of C. trachomatis growth in CWR-R1 cells.…”
Get full text

REHABILITATION EFFECT OF CORRECTION OF ERECTILE DYSFUNCTION IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY FOR PROSTATE CANCER by A. T. Asratov, I. V. Vinogradov, B. R. Gvasaliya, A. A. Kachmazov, A. G. Kochetov, Yu. V. Samsonov, N. V. Sitnikov, A. O. Tolkachev, A. A. Kostin

Subjects: “…prostate cancer…”
Get full text

Physical Performance and Activity in Older Prostate Cancer Survivors in Comparison with Population-based Matched Controls by Reidun Sletten, Marit Slaaen, Line Merethe Oldervoll, Håvard Kjesbu Skjellegrind, Jūratė Šaltytė Benth, Lennart Åstrøm, Øyvind Kirkevold, Sverre Bergh, Bjørn Henning Grønberg, Siri Rostoft, Asta Bye, Paul Jarle Mork, Ola Berger Christiansen

Subjects: Get full text

Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis by Xiaoying Tang, Zhenyu Liu, Liangdong Song, Huixuan Zhu, Shuai Su, Delin Wang

Subjects: “…prostate cancer…”
Get full text

12 Predicting pathological tumor volume in prostate cancer lesions using micro-ultrasound and MRI by A. Rakauskas, A. Richmond, S. La Rosa, N. Vietti-Violi, M. Valerio

Get full text

Bioinformatics analysis combined with experimental validation reveals the biological role of the ILK gene in prostate cancer by Xiao-xiang Yu, Yi Liu, Rong-jiang Luo, Zi-xuan Song, Wen-kai Chen, Zeng-mi Mo, Feng-jing Wang

Subjects: “…Prostate cancer…”
Get full text

Osteoblast‐Derived ECM1 Promotes Anti‐Androgen Resistance in Bone Metastatic Prostate Cancer by Xinwen Wang, Min Wang, Qijun Lin, Lixin He, Baolin Zhang, Xin Chen, Guanhong Chen, Hong Du, Chuandong Lang, Xinsheng Peng, Yuhu Dai

Subjects: Get full text

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer by Matthew Sean Peach, Timothy N. Showalter, Nitin Ohri

“…Prostate Cancer…”
Get full text

Correction: Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer by Minmin Lan, Lianhua Zhu, Yixuan Wang, Daijia Shen, Kejing Fang, Yu Liu, Yanli Peng, Bin Qiao, Yanli Guo

Get full text

Identification of mitochondrial carrier homolog 2 as an important therapeutic target of castration-resistant prostate cancer by Yankui Liu, Anjie Chen, Yufan Wu, Jiang Ni, Rong Wang, Yong Mao, Ning Sun, Yuanyuan Mi

“…Abstract We here investigate the expression of the mitochondrial carrier homolog 2 (MTCH2) and its potential function in castration-resistant prostate cancer (CRPC). Bioinformatic analyses reveal that MTCH2 overexpression is associated with critical clinical parameters of prostate cancer. …”
Get full text

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men by Abudu EK, Okuku CN, Akaiso OE, Fabian UA, Udoh EA, Ukpong AE, Kudamnya IJ, Ajayi OO, Uduma FU, Abudu OO, Ekpo BO

Subjects: Get full text

Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires by László Gesztesi, Zsuzsa S. Kocsis, Kliton Jorgo, Georgina Fröhlich, Csaba Polgár, Péter Ágoston

“…Prostate Cancer…”
Get full text

Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis by Renliang Yi, Baoxin Chen, Peng Duan, Chanjiao Zheng, Huanyu Shen, Qun Liu, Chen Yuan, Weilin Ou, Zhiheng Zhou

“…New treatments, such as sipuleucel-T and androgen receptor- (AR-) directed therapies (enzalutamide (Enz) and abiraterone acetate (AA)), have emerged and been approved for the management of castration-resistant prostate cancer (CRPC). There are still debates over their efficacy and clinical benefits. …”
Get full text

Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer by O. A. Mailyan, K. Yu. Kanukoev, P. G. Berezin, K. M. Nyushko, V. A. Gorbach

Subjects: Get full text

Use of Step-Section Histopathology to Evaluate F-Fluorocholine PET Sextant Localization of Prostate Cancer by Sandi A. Kwee, Gregory P. Thibault, Richard S. Stack, Marc N. Coel, Bungo Furusato, Isabell A. Sesterhenn

“…Fluorocholine PET can serve to localize dominant areas of malignancy in patients with prostate cancer. However, PET with fluorocholine may fail to identify sextants with smaller volumes of malignancy.…”
Get full text